Skip to main content

SUSQUEHANNA INTERNATIONAL GROUP, LLP

Position in BIOA — BioAge Labs, Inc.

CIK 1446194 BALA CYNWYD, PA

Position in BIOA

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$1,050,956
+$357,189 QoQ
Shares Held
60,089
+14.6% QoQ
Ownership
0.135%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2025
5 quarters on record
Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Common Shares in BIOA Over Time

Shares Held

Position Value (USD)

Derivatives in BIOA

reported options exposure · as of Mar 31, 2026
CallValue
$0
CallShares
0
PutValue
$1,358,973
PutShares
77,700

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Mar 31, 2026

SUSQUEHANNA INTERNATIONAL GROUP, LLP holds $328,512,917 across 53 Drug Manufacturers - Specialty & Generic names. BIOA ranks #27 (0.3% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in BIOA

Export CSV
9 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $1,050,956 60,089
2026-03-31 $1,358,973 77,700
2025-12-31 $693,767 52,439
2025-09-30 $59,458 10,112
2025-09-30 $751,464 127,800
2025-06-30 $178,077 43,118
2025-06-30 $596,372 144,400
2025-03-31 $310,576 82,600
2025-03-31 $99,715 26,520